Hangyu Zhang

2.5k total citations · 2 hit papers
87 papers, 1.7k citations indexed

About

Hangyu Zhang is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Hangyu Zhang has authored 87 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 28 papers in Molecular Biology and 20 papers in Biomedical Engineering. Recurrent topics in Hangyu Zhang's work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (9 papers) and RNA Interference and Gene Delivery (8 papers). Hangyu Zhang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (9 papers) and RNA Interference and Gene Delivery (8 papers). Hangyu Zhang collaborates with scholars based in China, United States and Finland. Hangyu Zhang's co-authors include Weijia Fang, Yi Zheng, Weiqin Jiang, Xiaoxuan Tu, Peng Zhao, Nan Qin, Zhou Tong, Tingting Wang, Peilu Li and Shunfeng Cai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hangyu Zhang

79 papers receiving 1.7k citations

Hit Papers

Gut microbiome affects the response to anti-PD-1 immunoth... 2019 2026 2021 2023 2019 2024 100 200 300

Peers

Hangyu Zhang
Lei Yu China
Meng Jia China
Xiao Fu China
Yong Fang China
Chao Qian China
Yu Yao China
Lei Yu China
Hangyu Zhang
Citations per year, relative to Hangyu Zhang Hangyu Zhang (= 1×) peers Lei Yu

Countries citing papers authored by Hangyu Zhang

Since Specialization
Citations

This map shows the geographic impact of Hangyu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangyu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangyu Zhang more than expected).

Fields of papers citing papers by Hangyu Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hangyu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangyu Zhang. The network helps show where Hangyu Zhang may publish in the future.

Co-authorship network of co-authors of Hangyu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Hangyu Zhang. A scholar is included among the top collaborators of Hangyu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hangyu Zhang. Hangyu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xu, Lin, et al.. (2025). YOLOv5s-Based Lightweight Object Recognition with Deep and Shallow Feature Fusion. Electronics. 14(5). 971–971. 1 indexed citations
3.
Zhang, Hangyu, et al.. (2025). Current progress of in vitro vascular models on microfluidic chips. Biofabrication. 17(2). 22004–22004. 2 indexed citations
4.
Zhang, Hangyu, et al.. (2025). Speckle-based image reconstruction via uniform illumination in single multimode fiber endoscopic imaging systems. Optics & Laser Technology. 192. 113633–113633.
5.
Sun, Xue, et al.. (2025). Influence of Electrostatic Interactions on the Self-Assembly of Charged Peptides. Gels. 11(1). 80–80. 4 indexed citations
6.
Ли, Бин, Hangyu Zhang, Yang Gao, et al.. (2025). NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory study. Cancer Immunology Immunotherapy. 74(11). 341–341. 1 indexed citations
7.
Zhang, Hangyu, et al.. (2024). Identification of multimodal vortex optical orbital angular momentum in multimode fiber speckle patterns. Optics Communications. 573. 131009–131009. 4 indexed citations
8.
Zhang, Hangyu, Xiaoxuan Tu, Zhou Tong, et al.. (2024). The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient. Cancer Gene Therapy. 31(9). 1412–1426. 10 indexed citations
9.
Tu, Xiaoxuan, Yi Zheng, Chenglin Mu, et al.. (2024). S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function. Journal of Experimental & Clinical Cancer Research. 43(1). 72–72. 8 indexed citations
10.
Jin, Yuzhi, Hui Ren, Chun-Yu Lai, et al.. (2024). Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment. Biomaterials. 305. 122463–122463. 68 indexed citations breakdown →
11.
Li, Fangkun, Junhao Liu, Jiahe Chen, et al.. (2024). Boosting oxygen redox reversibility in chemo-mechanically robust Li-rich oxide cathodes via multi-scale defect design. Energy & Environmental Science. 18(3). 1241–1254. 19 indexed citations
12.
Bao, Yuxin, Hangyu Zhang, Danbo Wang, et al.. (2024). The Pathological Factors Involved in Current In Vitro Atherosclerotic Models. Tissue Engineering Part B Reviews. 30(5). 530–544. 1 indexed citations
13.
Fu, Qihan, Yi Zheng, Weijia Fang, et al.. (2023). RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial. EClinicalMedicine. 63. 102175–102175. 46 indexed citations
14.
Wang, Cunli, et al.. (2023). Advances in Alzheimer’s Disease-Associated Aβ Therapy Based on Peptide. International Journal of Molecular Sciences. 24(17). 13110–13110. 7 indexed citations
15.
Qin, Kai‐Rong, et al.. (2023). Visualization of Cell Membrane Tension Regulated by the Microfilaments as a “Shock Absorber” in Micropatterned Cells. Biology. 12(6). 889–889. 1 indexed citations
16.
Zheng, Yi, Tingting Wang, Xiaoxuan Tu, et al.. (2019). Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 7(1). 193–193. 392 indexed citations breakdown →
17.
Zheng, Hongbo, Aihong Peng, Jiahui Ma, et al.. (2019). Strepantibins A–C: Hexokinase II Inhibitors from a Mud Dauber Wasp Associated Streptomyces sp.. Journal of Natural Products. 82(5). 1114–1119. 21 indexed citations
18.
Cong, Yan, Xiaoxuan Tu, Wei Wu, et al.. (2019). Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?. World Journal of Clinical Cases. 7(11). 1253–1261. 13 indexed citations
20.
Zhang, Hangyu, Rujiao Liu, Lulu Liu, et al.. (2018). Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients. Translational Oncology. 12(3). 426–431. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026